Li-Wei Liu Selected Research

Infections

5/2023	Exploiting Natural Maltol for Synthesis of Novel Hydroxypyridone Derivatives as Promising Anti-Virulence Agents in Bactericides Discovery.
12/2021	Synthesis and Biological Evaluation of 1,2,4-Triazole Thioethers as Both Potential Virulence Factor Inhibitors against Plant Bacterial Diseases and Agricultural Antiviral Agents against Tobacco Mosaic Virus Infections.
4/2021	Rational Optimization of 1,2,3-Triazole-Tailored Carbazoles As Prospective Antibacterial Alternatives with Significant In Vivo Control Efficiency and Unique Mode of Action.
8/2020	Synthesis and Docking Study of N-(Cinnamoyl)-N'-(substituted)acryloyl Hydrazide Derivatives Containing Pyridinium Moieties as a Novel Class of Filamentous Temperature-Sensitive Protein Z Inhibitors against the Intractable Xanthomonas oryzae pv. oryzae Infections in Rice.
12/2019	Design, Synthesis, Antibacterial Evaluation, and Induced Apoptotic Behaviors of Epimeric and Chiral 18β-Glycyrrhetinic Acid Ester Derivatives with an Isopropanolamine Bridge against Phytopathogens.
2/2016	[A 5-year retrospective clinical study of perinatal cytomegalovirus infection].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Wei Liu Research Topics

Disease

18	Bacterial Infections (Bacterial Infection) 04/2024 - 08/2015
6	Infections 05/2023 - 02/2016
6	Neoplasms (Cancer) 02/2021 - 10/2010
4	Inflammation (Inflammations) 01/2023 - 01/2017
3	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2017
2	Virus Diseases (Viral Diseases) 11/2023 - 10/2023
2	Starvation 02/2023 - 11/2021
2	Body Weight (Weight, Body) 09/2022 - 03/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2021 - 01/2016
2	Hypoxia (Hypoxemia) 02/2021 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
2	Oral Lichen Planus 01/2021 - 01/2020
2	Asthma (Bronchial Asthma) 11/2019 - 01/2019
1	Fistula 03/2024
1	Pancreatitis 01/2023
1	Dysbiosis 01/2023
1	Thromboangiitis Obliterans (Buerger's Disease) 09/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2022
1	Serositis 07/2022
1	Central Serous Chorioretinopathy 07/2022
1	Lupus Nephritis 07/2022
1	Leukopenia 07/2022
1	Thrombosis (Thrombus) 09/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2021
1	Sarcoma (Soft Tissue Sarcoma) 09/2020
1	Adenocarcinoma 09/2020
1	Primary Myelofibrosis (Myelosclerosis) 09/2020
1	Autoimmune Pancreatitis 06/2020
1	Pancreatic Diseases (Pancreatic Disease) 06/2020
1	Immunoglobulin G4-Related Disease 06/2020
1	Heart Failure 03/2020
1	Death (Near-Death Experience) 03/2020
1	Pancreatic Fistula (Pancreatic Fistulas) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020

Drug/Important Bio-Agent (IBA)

8	Agrochemicals (Agricultural Chemicals)IBA 04/2024 - 10/2019
7	Anti-Bacterial Agents (Antibiotics)IBA 05/2023 - 04/2019
5	Virulence Factors (Pathogenicity Factors)IBA 04/2024 - 12/2021
4	Proteins (Proteins, Gene)FDA Link 06/2020 - 01/2013
3	PesticidesIBA 04/2024 - 04/2021
3	1,3,4-oxadiazoleIBA 02/2023 - 04/2019
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	Antiviral Agents (Antivirals)IBA 11/2023 - 12/2021
2	monoisopropanolamineIBA 07/2023 - 05/2022
2	EnzymesIBA 05/2023 - 01/2016
2	Sulfides (Thioethers)IBA 12/2021 - 04/2019
2	HydrazinesIBA 08/2021 - 08/2020
2	Therapeutic UsesIBA 01/2019 - 02/2016
2	Cadherins (E-Cadherin)IBA 05/2018 - 06/2015
1	Gentian Violet (Violet, Crystal)FDA Link 04/2024
1	CollagenIBA 03/2024
1	phenothiazineIBA 11/2023
1	rutecarpineIBA 10/2023
1	cinnamic acidIBA 07/2023
1	Triclosan (pHisoHex)FDA Link 07/2023
1	benzothiazoleIBA 05/2023
1	Polysaccharides (Glycans)IBA 05/2023
1	SulfonamidesIBA 03/2023
1	piperidineIBA 03/2023
1	Type III Secretion SystemsIBA 02/2023
1	Nicotinamide MononucleotideIBA 01/2023
1	Sirtuin 3IBA 01/2023
1	Hematoxylin (Haematoxylon)IBA 09/2022
1	Troleandomycin (TAO)FDA Link 09/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2022
1	AutoantibodiesIBA 07/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2022
1	AntibodiesIBA 07/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 07/2022
1	CoumarinsIBA 05/2022
1	1,2,4-triazoleIBA 12/2021
1	ChromatinIBA 11/2021
1	pyrazoleIBA 08/2021
1	CopperIBA 04/2021
1	Oxygen (Dioxygen)IBA 02/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2021
1	fuzheng yiliuIBA 01/2021
1	fedratinibIBA 09/2020
1	Janus Kinase 2IBA 09/2020
1	PiperazineIBA 09/2020
1	AmidesIBA 09/2020
1	plasma protein Z (protein Z)IBA 08/2020
1	Immunoglobulin G (IgG)IBA 06/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2020
1	sacubitril and valsartan sodium hydrate drug combinationIBA 03/2020
1	Neprilysin (Neutral Endopeptidase)IBA 03/2020
1	biapenem (L 627)IBA 01/2020
1	Drug CombinationsIBA 01/2020
1	XuebijingIBA 01/2020
1	asiatic acidIBA 01/2020
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2019
1	CholesterolIBA 11/2019

Therapy/Procedure

2	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2022 - 11/2019
1	Transplantation 01/2023
1	Stents 09/2021
1	Drug-Eluting Stents 09/2021
1	Photochemotherapy (Photodynamic Therapy) 02/2021
1	Lasers (Laser) 02/2021
1	Pancreaticoduodenectomy 01/2020